INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2015

Pretreatment with DHEA significantly increased live birth rates and decreased miscarriage rates in infertile women aged 36 to 40 undergoing IVF.

In a double-blind, randomized, placebo-controlled study, 109 infertile women aged 36-40 years undergoing a long protocol IVF received either 75 mg of DHEA daily or placebo starting eight weeks before the IVF cycle and continuing during treatment. Patients in the DHEA group achieved a significantly higher live birth rate compared with the control group (P<0.05). Conversely, the miscarriage rate was significantly higher in the control group than in the DHEA group (P<0.05).

Study type
Double-blind, randomized, placebo-controlled study
Who was studied
109 infertile patients aged 36-40 years with normal ovarian reserve
What was measured
Clinical pregnancy, live birth, and miscarriage rates, plus standard IVF parameters

THE PAPER

Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.

Tartagni M, Cicinelli MV, Baldini D, Tartagni MV, Alrasheed H, DeSalvia MA, Loverro G, Montagnani M. Reprod Biol Endocrinol, 2015.

PubMed 25884390 ↗DOI 10.1016/j.placenta.2008.08.015 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.